Showing results (1541-1550 of 1,599) with videos related to
Sort By:
Pageof 160
Bone Marrow Transplantation|April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemiaZ S Pavletic, E R Arrowsmith, P J Bierman, et al.Bone Marrow Transplantation|November 8, 2019
Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosisRohan Gupta, Faizi Jamal, Dongyun Yang, et al.Blood|December 3, 2017
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemiaEytan M Stein, Roland B Walter, Harry P Erba, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remissionAnthony S Stein, Margaret R O'Donnell, Marilyn L Slovak, et al.Leukemia|September 26, 2021
Spred1 deficit promotes treatment resistance and transformation of chronic phase CMLJunjing Qiao, Chen Liang, Dandan Zhao, et al.Blood|July 7, 2026
Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell NeoplasmAndrew A Lane, Marlise R Luskin, Julia H Keating, et al.Critical Reviews in Eukaryotic Gene Expression|February 27, 2021
A Peer-Based Strategy to Overcome HPV Vaccination Inequities in Rural Communities: A Physical Distancing-Compliant ApproachChristine Finley, Matthew J Dugan, Jan Kirk Carney, et al.Haematologica|June 16, 2018
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patientsIbrahim Aldoss, Tracey Stiller, Ni-Chun Tsai, et al.Cancer|October 11, 2021
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemiaIbrahim Aldoss, Salman Otoukesh, Jianying Zhang, et al.Journal of Cellular Biochemistry|June 21, 2018
Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2Héctor F Araya, Hugo Sepulveda, Carlos O Lizama, et al.Pageof 160